effectiveness evaluation of cognitive – evolutionary protocol in the outcome of Methadone Maintenance Treatment (MMT) patients who use metamphetamin simultaneously.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211201053246N1

Enrollment

Registered

2022-05-25

Start date

2022-04-09

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

substance use disorder. Other psychoactive substance abuse

Interventions

Intervention 1: cognitive – evolutionary protocol (Intervention group): Evolutionary cognitive therapy is a psychotherapy based on cognitive therapies that address the distant or evolutionary causes o

Therefore, both groups will receive this treatment.

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: one month passed from treatment. diognosed as Methamphetamin use disorder by Urine test having at least 18 years. 4-being able to read and write.

Exclusion criteria

Exclusion criteria: having serious medical problem. being diognosed as psychotic by SCID3 interview.

Design outcomes

Primary

Measure	Time frame
Quality of Life. Timepoint: Before the intervention, after the intervention and 3 months after the intervention. Method of measurement: WHOQOL-BREF Quality of Life Short Scale Form.;Evolutionary Fitness. Timepoint: Before the intervention, after the intervention and 3 months after the intervention. Method of measurement: Evolutionary Fitness Scale.;Self Efficasy. Timepoint: Before the intervention, after the intervention and 3 months after the intervention. Method of measurement: Sherer Self Efficasy Scale.;Social Support. Timepoint: Before the intervention, after the intervention and 3 months after the intervention. Method of measurement: Social Support Appraisals.;Aversive Emotions. Timepoint: Before the intervention, after the intervention and 3 months after the intervention. Method of measurement: Depression Anxiety Stress Scale.;Avoid taking methamphetamine. Timepoint: Before the intervention, after the intervention and 3 months after the intervention. Method of measurement: Methamphetamine negative test.	—

Measure

Time frame

Quality of Life. Timepoint: Before the intervention, after the intervention and 3 months after the intervention. Method of measurement: WHOQOL-BREF Quality of Life Short Scale Form.;Evolutionary Fitness. Timepoint: Before the intervention, after the intervention and 3 months after the intervention. Method of measurement: Evolutionary Fitness Scale.;Self Efficasy. Timepoint: Before the intervention, after the intervention and 3 months after the intervention. Method of measurement: Sherer Self Efficasy Scale.;Social Support. Timepoint: Before the intervention, after the intervention and 3 months after the intervention. Method of measurement: Social Support Appraisals.;Aversive Emotions. Timepoint: Before the intervention, after the intervention and 3 months after the intervention. Method of measurement: Depression Anxiety Stress Scale.;Avoid taking methamphetamine. Timepoint: Before the intervention, after the intervention and 3 months after the intervention. Method of measurement: Methamphetamine negative test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFahime Lavasani

Iran University of Medical Sciences

lavasani.f@iums.ac.ir+98 21 86701

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026